Lipids in Health and Disease

Papers
(The H4-Index of Lipids in Health and Disease is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease87
The impact of reactive oxygen species in the development of cardiometabolic disorders: a review76
Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis56
Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study52
A review on gut microbiota: a central factor in the pathophysiology of obesity50
Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal stud49
Association between triglyceride-glucose index and risk of incident diabetes: a secondary analysis based on a Chinese cohort study46
Age and sex are associated with the plasma lipidome: findings from the GOLDN study46
Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion44
Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing t43
Triglyceride glucose-body mass index in identifying high-risk groups of pre-diabetes41
Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis40
Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women39
Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States37
LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study36
Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy36
Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population36
High-density Lipoprotein Cholesterol Is Negatively Correlated with Bone Mineral Density and Has Potential Predictive Value for Bone Loss35
Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran34
Lipid metabolism within the bone micro-environment is closely associated with bone metabolism in physiological and pathophysiological stages33
Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study32
Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease32
Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity32
Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson’s, Martin’s and Friedewald’s equations32
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection32
Identification of lipidomic profiles associated with drug-resistant prostate cancer cells30
High density lipoproteins and oxidative stress in breast cancer29
Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer29
Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis28
The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B28
Sphingolipid lysosomal storage diseases: from bench to bedside28
0.050894975662231